Related Overviews


'myelosuppression' can also refer to...


myelosuppression n.

myelosuppression n.

myelosuppression n.

myelosuppression n.

Serum Cytokine Level Fluctuations in Chemotherapy-induced Myelosuppression

Parvovirus B19 infection associated with myelosuppression and cutaneous polyarteritis nodosa

Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests

No Effect of Pyridoxine on the Incidence of Myelosuppression during Prolonged Linezolid Treatment

Identification of thiopurine methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprine.

OP035 NUDT15 variants contribute to thiopurine-induced myelosuppression in European populations

Pretreatment haematological laboratory values predict for excessive myelosuppression in patients receiving adjuvant FEC chemotherapy for breast cancer

Chronic Myelosuppression Associated with Persistent Bone Marrow Infection Due to Human Herpesvirus 6 in a Bone Marrow Transplant Recipient

P08.05 Combined presence of three MGMT gene-polymorphisms in a glioblastoma patient, who developed severe myelosuppression following temozolomide chemotherapy

Prevention of myelosuppression and genotoxicity induced by cisplatin in murine bone marrow cells: effect of an organovanadium compound vanadium(III)-l-cysteine

Myelosuppression and Serotonin Syndrome Associated with Concurrent Use of Linezolid and Selective Serotonin Reuptake Inhibitors in Bone Marrow Transplant Recipients

Systemic Effects of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor in Combination with Recombinant Murine Granulocyte Colony-Stimulating Factor in a Murine Model of Myelosuppression

Disease-modifying anti-rheumatic drugs are only one of a number of potential causes of myelosuppression: a careful drug history is necessary to elucidate the cause of an adverse event


More Like This

Show all results sharing this subject:

  • Medicine and Health


Show Summary Details

Quick Reference

n. a reduction in blood-cell production by the bone marrow. It commonly occurs after chemotherapy and may result in anaemia, infection, and abnormal bleeding (see thrombocytopenia, neutropenia). —myelosuppressiveadj.

Subjects: Medicine and Health.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.